Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030
... 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
Bleeding Disorders Treatment Market by Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease), Drug Class (Antibrinolytics, Desmopressin, Fibrin Sealant), Distribution Channel - Global Forecast 2023-2030
... USD 25.25 billion by 2030 from USD 12.42 billion in 2022, at a CAGR of 9.27% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging ... Read More
-
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region and Competition
... with a CAGR of 5.76% through 2028. Hospitals play a vital role in the healthcare sector, serving as a significant revenue source for the industry and driving research and advancements in the field. Healthcare product ... Read More
-
Plasma Fractionation Market, 2023-2035
... ~10% during the forecast period. Over the past two decades, the number of patients affected with rare diseases have increased tremendously. In fact, over 410 million people are currently suffering from rare and chronic disorders. ... Read More
-
Global Alpha Thalassemia Market - 2023-2030
... forecast period 2023-2030. The alpha thalassemia market trends show rising research owing to the rising technological advancements. When one or more of the four alpha-globin genes—which are responsible for producing hemoglobin—are damaged or absent, alpha ... Read More
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
... size is projected to reach USD 40.4 billion by 2028 from USD 29.0 billion in 2023, at a CAGR of 6.9% during the forecast period. Expanding the number of plasma collection centers allows market players ... Read More
-
Plasma Fractionation Global Market Briefing 2023
... (CAGR) of 7.35%. The global plasma fractionation market is expected to grow from $26.39 billion in 2022 to $69.35 billion in 2032 at a CAGR of 10.14%. Plasma Fractionation Global Market Briefing 2023 provides strategists, ... Read More
-
2023 Blood & AutoImmune Diseases Global Market Size & Growth Report with Global Recession Risk Impact
... share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The historical data ... Read More
-
Sickle Cell Disease - Epidemiology Forecast - 2032
... shape leads to complications, including chronic pain, organ damage, and increased susceptibility to infections. SCD is a global health concern, particularly prevalent in populations with African, Middle Eastern, Mediterranean, and South Asian ancestry. The primary ... Read More
-
Global Blood Plasma Market: Analysis By Demand, By Production Capacity, By Type, By Industry, By Application, By Region, Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028
... component of blood, plays a vital role in the field of medicine. Comprising proteins, hormones, electrolytes, and antibodies, it serves as a crucial resource for various therapeutic applications. Blood plasma holds significant medical importance due ... Read More
-
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
... the 3MM, at an AGR of 0.61%. Currently, the treatment regimen for vWD in the 3MM is mostly limited to DDAVP and coagulation factor VIII + vWF complex. There are several unmet needs in this ... Read More
-
Global Anemia Gene Detection Kits Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... USD 229.5 million in 2022 and is forecast to a readjusted size of USD 310.2 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were ... Read More
-
Global Anemia Gene Detection Kits Supply, Demand and Key Producers, 2023-2029
... CAGR during the forecast period (2023-2029). This report studies the global Anemia Gene Detection Kits production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for ... Read More
-
Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030 Given ... Read More
-
2023 Global Forecast for Plasma Fractionation Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030
... & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030 Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% ... Read More
-
Global Hemophilia Market - 2023-2030
... expected to exhibit a CAGR of 5.9% during the forecast period 2023-2030. A spectrum of conditions impacting the body's blood clotting function is comprehended as bleeding disorders. Heeding an injury, multiple disorders can induce extreme ... Read More
-
Fanconi Anemia Drug Market
... By Disease Stage (Early-stage Disease, Advanced-stage Disease), By Research Status (FDA-approved Drugs, Clinical Trials, Pre-clinical Studies, Pipeline Drugs), By Patient Setting (Inpatient Settings, Outpatient Settings), and By Geography (North America, Europe, Asia Pacific, Latin America, ... Read More
-
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Von Willebrand Disease (vWD) Clinical trials scenario. This report provides top line data ... Read More
-
2023 Czech Republic Anemia Diagnostic Testing Market Assessment - 2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... from any other published source , including: - 2022 Supplier Sales and Shares by Segment and Test 2022-2027 Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities ... Read More
-
Global Chemotherapy-Induced Anemia Market - 2023-2030
... chemotherapy-induced anemia market is expected to exhibit a cagr of 7.2% during the forecast period (2023-2030). Anemia is a condition in which the body's status of red blood cells goes below normal. When the body ... Read More
-
Global Anemia Gene Detection Kits Market Growth 2023-2029
... to grow at a CAGR of 4.8% from 2023 to 2029. United States market for Anemia Gene Detection Kits is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Hemophilia Treatment Drugs Market Research Report 2023(Status and Outlook)
... Treatment Drugs Market Size was estimated at USD 10830.00 million in 2022 and is projected to reach USD 13778.78 million by 2029, exhibiting a CAGR of 3.50% during the forecast period. Bosson Research’s latest report ... Read More
-
Iron Deficiency Anemia (IDA) Therapy Market Forecasts to 2028 – Global Analysis By Therapy (Parenteral Iron Therapy, Oral Iron Therapy, Red Blood Cell Transfusion Therapy and Other Therapies), Therapy Area (Congestive Heart Failure (CHF), Renal, Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography
... Obstetrics & Gynaecology, Oncology, Inflammatory Bowel Disease and Other Therapy Areas), Age, End User and By Geography According to Stratistics MRC, the Global Iron Deficiency Anemia (IDA) Therapy Market is accounted for $1.87 billion in ... Read More
Research Assistance
